State-backed The Innovation Network Corporation of Japan invests cancer drug company Anaeropharma Science
The Innovation Network Corporation of Japan (INCJ) will inject JPY700 million ($8.7 million) in Anaeropharma Science, a privately-held biopharmaceutical company based in Tokyo, according to Japan's Nihon Keizai Shimbun.
Established in 2004, Anaeropharma Science engages in the development of novel therapeutics to target solid cancers based, on a proprietary platform technology called recombinant bifidobacterium therapeutics,...
More on Early-stage
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.